2021-01-03
Published Date
Life Science
Industry
114
Pages
Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Immune Checkpoint Inhibitors market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Immune Checkpoint Inhibitors market segmented into
PD-1/PD-L1
CTLA-4
Based on the end-use, the global Immune Checkpoint Inhibitors market classified into
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Melanoma
Blood Cancer
Others
Based on geography, the global Immune Checkpoint Inhibitors market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Bristol Myer Squibb
AstraZeneca
Merck & Co.
Roche / Genentech
Incyte Corporation
NewLink Genetics
ArGEN-X
Seattle Genetics
Pfizer
MacroGenics
Celldex Therapeutics
CureTech
Immutep
Innate Pharma
Sorrento Therapeutics
GlaxoSmithKline
GITR, Inc
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL IMMUNE CHECKPOINT INHIBITORS INDUSTRY
2.1 Summary about Immune Checkpoint Inhibitors Industry
2.2 Immune Checkpoint Inhibitors Market Trends
2.2.1 Immune Checkpoint Inhibitors Production & Consumption Trends
2.2.2 Immune Checkpoint Inhibitors Demand Structure Trends
2.3 Immune Checkpoint Inhibitors Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 PD-1/PD-L1
4.2.2 CTLA-4
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Lung Cancer
4.3.2 Colorectal Cancer
4.3.3 Breast Cancer
4.3.4 Prostate Cancer
4.3.5 Melanoma
4.3.6 Blood Cancer
4.3.7 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 PD-1/PD-L1
5.2.2 CTLA-4
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Lung Cancer
5.3.2 Colorectal Cancer
5.3.3 Breast Cancer
5.3.4 Prostate Cancer
5.3.5 Melanoma
5.3.6 Blood Cancer
5.3.7 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 PD-1/PD-L1
6.2.2 CTLA-4
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Lung Cancer
6.3.2 Colorectal Cancer
6.3.3 Breast Cancer
6.3.4 Prostate Cancer
6.3.5 Melanoma
6.3.6 Blood Cancer
6.3.7 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 PD-1/PD-L1
7.2.2 CTLA-4
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Lung Cancer
7.3.2 Colorectal Cancer
7.3.3 Breast Cancer
7.3.4 Prostate Cancer
7.3.5 Melanoma
7.3.6 Blood Cancer
7.3.7 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 PD-1/PD-L1
8.2.2 CTLA-4
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Lung Cancer
8.3.2 Colorectal Cancer
8.3.3 Breast Cancer
8.3.4 Prostate Cancer
8.3.5 Melanoma
8.3.6 Blood Cancer
8.3.7 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 PD-1/PD-L1
9.2.2 CTLA-4
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Lung Cancer
9.3.2 Colorectal Cancer
9.3.3 Breast Cancer
9.3.4 Prostate Cancer
9.3.5 Melanoma
9.3.6 Blood Cancer
9.3.7 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bristol Myer Squibb
10.1.2 AstraZeneca
10.1.3 Merck & Co.
10.1.4 Roche / Genentech
10.1.5 Incyte Corporation
10.1.6 NewLink Genetics
10.1.7 ArGEN-X
10.1.8 Seattle Genetics
10.1.9 Pfizer
10.1.10 MacroGenics
10.1.11 Celldex Therapeutics
10.1.12 CureTech
10.1.13 Immutep
10.1.14 Innate Pharma
10.1.15 Sorrento Therapeutics
10.1.16 GlaxoSmithKline
10.1.17 GITR, Inc
10.2 Immune Checkpoint Inhibitors Sales Date of Major Players (2017-2020e)
10.2.1 Bristol Myer Squibb
10.2.2 AstraZeneca
10.2.3 Merck & Co.
10.2.4 Roche / Genentech
10.2.5 Incyte Corporation
10.2.6 NewLink Genetics
10.2.7 ArGEN-X
10.2.8 Seattle Genetics
10.2.9 Pfizer
10.2.10 MacroGenics
10.2.11 Celldex Therapeutics
10.2.12 CureTech
10.2.13 Immutep
10.2.14 Innate Pharma
10.2.15 Sorrento Therapeutics
10.2.16 GlaxoSmithKline
10.2.17 GITR, Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Immune Checkpoint Inhibitors Product Type Overview
Table Immune Checkpoint Inhibitors Product Type Market Share List
Table Immune Checkpoint Inhibitors Product Type of Major Players
Table Brief Introduction of Bristol Myer Squibb
Table Brief Introduction of AstraZeneca
Table Brief Introduction of Merck & Co.
Table Brief Introduction of Roche / Genentech
Table Brief Introduction of Incyte Corporation
Table Brief Introduction of NewLink Genetics
Table Brief Introduction of ArGEN-X
Table Brief Introduction of Seattle Genetics
Table Brief Introduction of Pfizer
Table Brief Introduction of MacroGenics
Table Brief Introduction of Celldex Therapeutics
Table Brief Introduction of CureTech
Table Brief Introduction of Immutep
Table Brief Introduction of Innate Pharma
Table Brief Introduction of Sorrento Therapeutics
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of GITR, Inc
Table Products & Services of Bristol Myer Squibb
Table Products & Services of AstraZeneca
Table Products & Services of Merck & Co.
Table Products & Services of Roche / Genentech
Table Products & Services of Incyte Corporation
Table Products & Services of NewLink Genetics
Table Products & Services of ArGEN-X
Table Products & Services of Seattle Genetics
Table Products & Services of Pfizer
Table Products & Services of MacroGenics
Table Products & Services of Celldex Therapeutics
Table Products & Services of CureTech
Table Products & Services of Immutep
Table Products & Services of Innate Pharma
Table Products & Services of Sorrento Therapeutics
Table Products & Services of GlaxoSmithKline
Table Products & Services of GITR, Inc
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Immune Checkpoint Inhibitors Market Forecast (Million USD) by Region 2021f-2026f
Table Global Immune Checkpoint Inhibitors Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Immune Checkpoint Inhibitors Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Immune Checkpoint Inhibitors Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Immune Checkpoint Inhibitors Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Immune Checkpoint Inhibitors Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Immune Checkpoint Inhibitors Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Immune Checkpoint Inhibitors Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Immune Checkpoint Inhibitors Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Immune Checkpoint Inhibitors Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Immune Checkpoint Inhibitors Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PD-1/PD-L1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CTLA-4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PD-1/PD-L1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CTLA-4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PD-1/PD-L1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CTLA-4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PD-1/PD-L1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CTLA-4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PD-1/PD-L1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CTLA-4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PD-1/PD-L1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CTLA-4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Melanoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Bristol Myer Squibb 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of AstraZeneca 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Merck & Co. 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Roche / Genentech 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Incyte Corporation 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of NewLink Genetics 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of ArGEN-X 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Seattle Genetics 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of MacroGenics 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Celldex Therapeutics 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of CureTech 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Immutep 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Innate Pharma 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of Sorrento Therapeutics 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Immune Checkpoint Inhibitors Sales Revenue (Million USD) of GITR, Inc 2017-2020e